Expertise in
32
conditions

Dr. Samip R. Master

Hematology
Lsuhsc Shreveport
1501 Kings Hwy, 
Shreveport, LA 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
11 Years of Experience
Expertise in
32
conditions
Lsuhsc Shreveport
1501 Kings Hwy, 
Shreveport, LA 

Overview

Samip Master is a Hematologist practicing medicine in Shreveport, Louisiana. He has been practicing medicine for over 11 years.

Dr. Master is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Anemia, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 29 peer reviewed articles and participating in 6 clinical trials. Dr. Master is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in LA

Hospital Affiliations

University Of Texas Medical Branch Galveston
Hca Houston Healthcare Southeast
Willis Knighton Medical Center
Hca Houston Healthcare Clear Lake

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Lsuhsc Shreveport
1501 Kings Hwy, Shreveport, LA 71103
Other Locations
Texas Oncology PA
501 W Medical Center Blvd, Webster, TX 77598

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Enrollment Status: Recruiting
Publish Date: August 19, 2026
Intervention Type: Other, Biological, Drug
Study Drugs: Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone, Lenalidomide
Study Phase: Phase 3
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Enrollment Status: Recruiting
Publish Date: August 19, 2026
Intervention Type: Other, Biological, Drug
Study Drugs: Daratumumab, Dexamethasone, Lenalidomide
Study Phase: Phase 3
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 3
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Biological
Study Drugs: Ipilimumab, Nivolumab, Sargramostim
Study Phase: Phase 2/Phase 3
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men
Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other
Study Phase: Phase 3
View 4 Less Clinical Trials

29 Total Publications

Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United States.
Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United States.
Journal: Journal of onco-nephrology
Published: February 18, 2026
Similar Doctors
Expertise in
30
conditions
Expertise in
30
conditions
Referral may be required

BRFHH Shreveport LLC

1541 Kings Hwy, 
Shreveport, LA 
 (0.1 miles away)
318-675-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Richard Mansour is a Hematologist practicing medicine in Shreveport, Louisiana. Dr. Mansour is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobin SC Disease, Chronic Lymphocytic Leukemia (CLL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Mansour is currently accepting new patients.

Expertise in
118
conditions
Dr. Anil Veluvolu
Hematology | Oncology
Expertise in
118
conditions
Dr. Anil Veluvolu
Hematology | Oncology
Referral may be required

Willis Knighton Hematology/Oncology North

2600 Kings Hwy Ste 300, 
Shreveport, LA 
 (1.0 miles away)
318-333-6270
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Anil Veluvolu is a Hematologist and an Oncologist practicing medicine in Shreveport, Louisiana. Dr. Veluvolu is highly rated in 118 conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Colorectal Cancer, Lynch Syndrome, and Liver Embolization. Dr. Veluvolu is currently accepting new patients.

Expertise in
50
conditions
Dr. Sakeer Hussain
Hematology | Oncology
Expertise in
50
conditions
Dr. Sakeer Hussain
Hematology | Oncology
Referral may be required

Lsuhsc Shreveport

1501 Kings Hwy, 
Shreveport, LA 
 (0.1 miles away)
318-813-1057
Languages Spoken:
English, Burmese, Hindi, Malay, Malayalam
See accepted insurances
Accepting New Patients
Offers Telehealth

Sakeer Hussain is a Hematologist and an Oncologist practicing medicine in Shreveport, Louisiana. Dr. Hussain is highly rated in 50 conditions, according to our data. His clinical expertise encompasses Chronic Familial Neutropenia, Paget Disease of the Breast, Colorectal Cancer, and Lynch Syndrome. Dr. Hussain is currently accepting new patients.

Frequently Asked Questions about Dr. Samip R. Master

How do I make an appointment with Dr. Samip R. Master?

You can book an appointment with Dr. Samip R. Master by calling their office at 318-813-2528. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Samip R. Master a top-rated expert for Sickle Cell Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Samip R. Master is classified as an Distinguished expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Samip R. Master specialize in?

While Dr. Samip R. Master is a Hematology, they have specific expertise in Sickle Cell Disease, Anemia, and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Samip R. Master participate in research or clinical trials?

Yes. Dr. Samip R. Master has published 29 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Dr. Samip R. Master's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Samip R. Master accept my insurance?

Dr. Samip R. Master accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 318-813-2528 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Master's expertise for a condition
ConditionClose
    View All 30 Advanced Conditions
    View All 74 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile